[Therapy of bronchitis in childhood with Eprazinone (author's transl)].

Abstract

This study should demonstrate the efficiency of a new bronchosecretolytic substance, Eprazinone, in therapy of acute and chronic bronchitis with children. The following groups of children have been treated: 1) 10 children with acute bronchitis (aged 5-14 years); 2) 12 children with chronic bronchitis (aged 7-14 years). To objectivize the effect of the substance, exact laboratory- and check-up examinations have been done daily. The dose was 3 x 1 tablet/day for school children, for younger children 2 x 1 suppository daily. All children have been treated over 5-8 days. The results of the therapy with Eprazinone in both groups show that -Eprazinone is an efficient remedy to cure symptomatically chronic and acute bronchitis in children. It shows an excellent mucolytic activity.

• Authors: Z Rudkowski, T Latos
• Journal: Padiatrie und Padologie (Padiatr Padol) Vol. 15 Issue 4 Pg. 351-64 ( 1980) ISSN: 0030-9338 [Print] Austria
• Vernacular Title: Behandlung von Bronchitiden bei Kindern mit Eprazinon.
• PMID: 7007990 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Expectorants
• Piperazines
• Propiophenones
• eprazinone

Topics

• Acute Disease
• Adolescent
• Bronchitis (drug therapy)
• Child
• Child, Preschool
• Chronic Disease
• Clinical Trials as Topic
• Expectorants (therapeutic use)
• Humans
• Piperazines (therapeutic use)
• Propiophenones (therapeutic use)